HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.

AbstractBACKGROUND:
Although lymph node metastasis (LNM) has been considered an important prognostic factor for intrahepatic cholangiocarcinoma (ICC), the impact of lymph node enlargement on the prognosis of ICC, and the accuracy of diagnosis of LNM, have not been fully clarified.
METHODS:
Using a chart review of 225 patients with ICC, we compared survival times between patients with and without lymph node enlargement, and we evaluated the accuracy of diagnosis of LNM. We also performed a multivariate analysis to determine the variables affecting overall survival in the study population.
RESULTS:
The survival time of patients without lymph node enlargement was significantly longer than that of patients with lymph node enlargement (median survival time [MST] 43.7 vs. 20.1 months; p = 0.007). However, in the group with enlarged lymph nodes, survival time was prolonged as a result of hepatectomy (MST 20.1 vs. 7.6 months; p < 0.01). The sensitivity of lymph node size and positron emission tomography-computed tomography findings for diagnosing LNM were 50.0 % (23/46) and 31.2 % (5/16), respectively, and were thus insufficient. Multivariate analysis identified the serum carcinoembryonic antigen (hazard ratio [HR] 1.830) and carbohydrate antigen 19-9 (HR 2.189) levels, blood transfusion (HR 1.792), intrahepatic metastasis (HR 1.988), and final stage (HR 8.684) as prognostic factors for overall survival, but lymph node enlargement was not identified as a prognostic factor.
CONCLUSION:
Preoperative evaluation of LNM proved to be difficult, and survival time in ICC patients with lymph node enlargement was prolonged as a result of hepatectomy. Thus, ICC patients with preoperative lymph node enlargement should not be prematurely deemed non-curative cases.
AuthorsTomohiko Adachi, Susumu Eguchi, Toru Beppu, Shinichi Ueno, Masayuki Shiraishi, Koji Okuda, Yo-Ichi Yamashita, Kazuhiro Kondo, Atsushi Nanashima, Masayuki Ohta, Yuko Takami, Tomoaki Noritomi, Kenji Kitahara, Hikaru Fujioka
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 22 Issue 7 Pg. 2269-78 (Jul 2015) ISSN: 1534-4681 [Electronic] United States
PMID25582737 (Publication Type: Journal Article, Multicenter Study)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms (mortality, pathology, surgery)
  • Cholangiocarcinoma (mortality, pathology, surgery)
  • Female
  • Follow-Up Studies
  • Hepatectomy (mortality)
  • Humans
  • Lymph Nodes (pathology, surgery)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Preoperative Care
  • Prognosis
  • Retrospective Studies
  • Survival Rate
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: